Harbour Investments, Inc. Blueprint Medicines Corp Transaction History
Harbour Investments, Inc.
- $3.14 Billion
- Q3 2024
A detailed history of Harbour Investments, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Harbour Investments, Inc. holds 200 shares of BPMC stock, worth $19,974. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$19,974
Previous $21,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BPMC
# of Institutions
342Shares Held
62.1MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$664 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$653 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$587 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$323 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$246 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.96B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...